Assessment of Clinical Effectiveness and Safety of Adalimumab and High Dose Methotrexate in Routine Clinical Practice
CompletedOBSERVATIONAL
Enrollment
346
Participants
Timeline
Start Date
October 11, 2012
Primary Completion Date
April 16, 2018
Study Completion Date
April 16, 2018
Conditions
Rheumatoid Arthritis
Interventions
DRUG
Adalimumab
Pre-filled syringe, administered by subcutaneous injection
All Listed Sponsors
lead
AbbVie (prior sponsor, Abbott)
INDUSTRY
NCT01736189 - Assessment of Clinical Effectiveness and Safety of Adalimumab and High Dose Methotrexate in Routine Clinical Practice | Biotech Hunter | Biotech Hunter